11:03 AM EDT, 08/22/2024 (MT Newswires) -- Kane Biotech ( KNBIF ) on Thursday said it signed a three-year distribution agreement with Razan Medical & Surgical Equipment Trading for its revyve Antimicrobial Wound Gel in the United Arab Emirates (UAE) wound care market

This is Kane's third distribution agreement for revyve. Kane had previously announced agreements with ProgenaCare Global for the U.S. wound care market and Salud Pharma for Colombia, Costa Rica and Panama. Kane also recently announced its intent to commercialize revyve in Canada.

"Kane continues to deliver on its commitment to commercialization with this first distribution agreement in the Middle East," said chief executive Marc Edwards.

Kane shares were last seen down $0.01 to $0.15 on the TSX Venture Exchange.

Price: 0.15, Change: -0.01, Percent Change: -3.23